Ocimum Biosolutions finds place in third annual Inc. 5000 list

Ocimum Biosolutions, a leading integrated life sciences solutions company, has been listed in the third annual Inc. 5000, an exclusive ranking of the America’s fastest-growing private companies. The list represents the most comprehensive look at the most important segment of the economy—America’s independent-minded entrepreneurs.

Anu Acharya, CEO, Ocimum Biosolutions, said, “We are excited to be listed amongst the fastest growing companies by Inc. magazine. It has been an exhilarating, fast and progressive 8 years for Ocimum since our inception in 2001. It has been very pleasing looking back at our progress and efforts we have put in for adding value through our increasing range of truly integrated genomics solutions.

“There is so much more to look forward to and we hope such genuine appreciation continues to come our way by doing what we do best which is letting our customers and community’s needs define our priorities. We will continue to invest in bringing about innovative range of genomics solutions which will add value to our diverse customer base,” she added.

“Savvy trend spotters and those who invest in private companies know that the Inc. 5000 is the best place to find out about young companies that are achieving success through a wide variety of unprecedented business models, as well as older private companies that are still expanding at an impressive rate,” said Inc. 5000 project manager Jim Melloan. “That’s why our list is so eagerly anticipated every year.”

Methodology

The Inc. 5000 is ranked according to percentage revenue growth from 2005 through 2008. To qualify, companies must have been founded and generating revenue by the first week of 2005, and therefore able to show four full calendar years of sales. Additionally, they have to be U.S.-based, privately held, for profit, and independent -- not subsidiaries or divisions of other companies -- as of December 31, 2008. Revenue in 2005 must have been at least $200,000, and revenue in 2008 must have been at least $2 million. The top 10 percent of companies on the list comprise the Inc. 500, now in its 28th year.